News
Guangdong runs a cross-border exercise for its Hong Kong-Macao drug and device scheme
AI-assisted summary Written by WellCareChina with AI assistance and checked against the original article.
The Guangdong Medical Products Administration said it held an exercise in Nansha on 23 September 2026 testing emergency response for the scheme that lets designated mainland hospitals in the Greater Bay Area use drugs and medical devices approved in Hong Kong or Macao. The administration said the scheme has covered 71 designated institutions, 178 products and nearly 30,000 patients since 2021, with 53 institutions on a traceability system.
Read the original article Opens the original source in a new tab.
Copyright and re-use
The original article is the authoritative text. This page carries our own summary and a link back; no part of the original is reproduced here.
Source tier B — headline, our own summary and a link back only; no full-text copy.